Position in LGVN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$21,090
New position
Shares Held
3,000
first reported quarter
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 39 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SCOTIA CAPITAL INC. holds $19,756,450 across 14 Biotechnology names. LGVN ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
1,343,726 | $8,882,028 | |
| 2 | BNTX |
BioNTech SE
|
45,000 | $4,187,250 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,981 | $3,467,672 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
34,722 | $1,633,322 | |
| 5 | EYPT |
EyePoint, Inc.
|
41,751 | $597,039 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
6,031 | $235,269 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
25,082 | $196,893 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
13,337 | $130,969 |
All Filings in LGVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,090 | 30,000 | Shares | Defined | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||